CB1R independent effects of cannabinoids on synaptic physiology in the CNS.

大麻素对中枢神经系统突触生理学的 CB1R 独立影响。

基本信息

  • 批准号:
    8225252
  • 负责人:
  • 金额:
    $ 18.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-03-01 至 2015-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This is a basic science proposal designed to use in vitro electrophysiological and optical techniques to further our understanding of an extremely unusual form of cannabinoid dependent signaling discovered in my lab. Specifically, we have observed that cannabinoid receptor agonists potentiate action potential independent release of GABA in the dentate gyrus through a cannabinoid type I (CB1) receptor independent mechanism. Although recent years have brought an enormous wealth of new information about the specific roles of endogenous cannabinoids in CNS physiology, the effect of cannabinoid receptor agonists that we have discovered appears to be unique in numerous respects. First, it does not depend on activation of CB1, CB2, or vanilloid type I receptors, and is still present in CB1-/- animals. Second, it clearly modulates action potential independent exocytotic events without altering action potential dependent events, and third, it ultimately results in the facilitation (rather than inhibition) of exocytosis. While our preliminary data represent significant progress towards characterizing a new role for cannabinoids in CNS physiology, many fundamental questions regarding this new phenomenon remain. Therefore this proposal requests funds to continue our investigation in this area through implementation of two Specific Aims. Aim 1 will test the hypothesis that cannabinoid mediated facilitation of action potential independent exocytosis depends on a specific ligand receptor interaction with an as yet unidentified GPCR. Specifically, we hypothesize that a G1s -> AC -> cAMP -> PKA signaling cascade is involved. Aim 2 will test the hypothesis that anandamide or one of its metabolites will be the most effective endogenously available ligand for facilitation of action potential independent release, and that the best agonists will work well within a physiologically relevant concentration range. Collectively, these Aims are designed to provide data that have the potential to clearly establish the significance of our findings for the cannabinoid field, and that will directly facilitate a longer term and larger scale investigation of the phenomenon. PUBLIC HEALTH RELEVANCE: Nearly all the known central effects of endogenous cannabinoids are thought to be mediated by activation of a single type of receptor, the CB1 cannabinoid receptor. We have recently discovered a highly novel form of cannabinoid mediated signaling that does not depend on CB1 receptor activation, and that has unique effects on CNS physiology. The current proposal is designed to address several fundamental questions about this new signaling system that we hope will ultimately establish the overall significance (and potential) of the finding.
描述(由申请人提供):这是一项基础科学提案,旨在利用体外电生理学和光学技术来进一步了解我的实验室发现的一种极其不寻常的大麻素依赖性信号传导形式。具体来说,我们观察到大麻素受体激动剂通过 I 型大麻素 (CB1) 受体独立机制增强齿状回中 GABA 的动作电位独立释放。尽管近年来关于内源性大麻素在中枢神经系统生理学中的具体作用带来了大量新信息,但我们发现的大麻素受体激动剂的作用在许多方面似乎都是独特的。首先,它不依赖于 CB1、CB2 或 I 型香草醛受体的激活,并且仍然存在于 CB1-/- 动物中。其次,它清楚地调节动作电位独立的胞吐事件,而不改变动作电位依赖性事件,第三,它最终导致胞吐作用的促进(而不是抑制)。虽然我们的初步数据代表了大麻素在中枢神经系统生理学中新作用的重大进展,但有关这一新现象的许多基本问题仍然存在。因此,该提案要求提供资金,通过实施两个具体目标来继续我们在这一领域的调查。目标 1 将检验大麻素介导的动作电位独立胞吐作用的促进取决于特定配体受体与尚未鉴定的 GPCR 的相互作用。具体来说,我们假设涉及 G1s -> AC -> cAMP -> PKA 信号级联。目标 2 将检验以下假设:anandamide 或其代谢物之一将是促进动作电位独立释放的最有效的内源性配体,并且最佳激动剂将在生理相关浓度范围内发挥良好作用。总的来说,这些目标旨在提供数据,这些数据有可能清楚地确定我们的研究结果对大麻素领域的重要性,并将直接促进对该现象进行更长期和更大规模的调查。 公共健康相关性:几乎所有已知的内源性大麻素的中心效应都被认为是由单一类型的受体(CB1 大麻素受体)的激活介导的。我们最近发现了一种高度新颖的大麻素介导的信号传导形式,它不依赖于 CB1 受体激活,并且对中枢神经系统生理学具有独特的影响。目前的提案旨在解决有关这个新信号系统的几个基本问​​题,我们希望这些问题最终能够确定该发现的总体意义(和潜力)。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Preformed vs. on-demand: molecular economics of endocannabinoid signalling.
预制与按需:内源性大麻素信号传导的分子经济学。
  • DOI:
    10.1113/jphysiol.2013.262717
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Frazier,CharlesJ
  • 通讯作者:
    Frazier,CharlesJ
Key questions of endocannabinoid signalling in the CNS: which, where and when?
中枢神经系统内源性大麻素信号传导的关键问题:哪个、在哪里、何时?
  • DOI:
    10.1113/jphysiol.2011.219493
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Frazier,CharlesJ
  • 通讯作者:
    Frazier,CharlesJ
Marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention.
  • DOI:
    10.1016/j.expneurol.2011.11.047
  • 发表时间:
    2013-06
  • 期刊:
  • 影响因子:
    5.3
  • 作者:
    Hofmann, Mackenzie E.;Frazier, Charles J.
  • 通讯作者:
    Frazier, Charles J.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHARLES J FRAZIER其他文献

CHARLES J FRAZIER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHARLES J FRAZIER', 18)}}的其他基金

Brain-gut-retina axis in diabetic retinopathy
糖尿病视网膜病变中的脑-肠-视网膜轴
  • 批准号:
    10595142
  • 财政年份:
    2023
  • 资助金额:
    $ 18.31万
  • 项目类别:
Novel Aspects of Central Oxytocin Signaling Relevant to Mood/Anxiety Disorders
与情绪/焦虑障碍相关的中枢催产素信号的新方面
  • 批准号:
    9014566
  • 财政年份:
    2015
  • 资助金额:
    $ 18.31万
  • 项目类别:
Novel Aspects of Central Oxytocin Signaling Relevant to Mood/Anxiety Disorders
与情绪/焦虑障碍相关的中枢催产素信号的新方面
  • 批准号:
    8888289
  • 财政年份:
    2015
  • 资助金额:
    $ 18.31万
  • 项目类别:
CB1R independent effects of cannabinoids on synaptic physiology in the CNS.
大麻素对中枢神经系统突触生理学的 CB1R 独立影响。
  • 批准号:
    8048639
  • 财政年份:
    2011
  • 资助金额:
    $ 18.31万
  • 项目类别:
Endocannabinoids and tonic GABA in the dentate gyrus.
齿状回中的内源性大麻素和补品 GABA。
  • 批准号:
    7093652
  • 财政年份:
    2005
  • 资助金额:
    $ 18.31万
  • 项目类别:
Endocannabinoids and tonic GABA in the dentate gyrus
齿状回中的内源性大麻素和补品 GABA
  • 批准号:
    7656750
  • 财政年份:
    2005
  • 资助金额:
    $ 18.31万
  • 项目类别:
Endocannabinoids and tonic GABA in the dentate gyrus
齿状回中的内源性大麻素和补品 GABA
  • 批准号:
    7460588
  • 财政年份:
    2005
  • 资助金额:
    $ 18.31万
  • 项目类别:
Endocannabinoids and tonic GABA in the dentate gyrus.
齿状回中的内源性大麻素和补品 GABA。
  • 批准号:
    7473458
  • 财政年份:
    2005
  • 资助金额:
    $ 18.31万
  • 项目类别:
Endocannabinoids and tonic GABA in the dentate gyrus
齿状回中的内源性大麻素和补品 GABA
  • 批准号:
    7242587
  • 财政年份:
    2005
  • 资助金额:
    $ 18.31万
  • 项目类别:
Endocannabinoids and tonic GABA in the dentate gyrus
齿状回中的内源性大麻素和补品 GABA
  • 批准号:
    6903677
  • 财政年份:
    2005
  • 资助金额:
    $ 18.31万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.31万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.31万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 18.31万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.31万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 18.31万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.31万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.31万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.31万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 18.31万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 18.31万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了